Experts Urge Health Regulators to Quickly Approve These New Drugs for Alzheimer's Disease
Health regulators are being strongly encouraged to swiftly approve two groundbreaking drugs for mild to moderate dementia stage of Alzheimer's disease.
United Kingdom Susan Kohlhaas Eli Lilly Treatment Options Drug Administration Alzheimer Research United Kingdom
Source: techtimes.com